ANAD SALEM: Open Payments
NPI 1659366839 · CARBONDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$794 in 42 payments from 15 companies in 2025. Trend: 2023 $1,056 · 2024 $1,040 · 2025 $794
Food & beverage: $794
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $156 |
| AstraZeneca Pharmaceuticals LP | 6 | $97 |
| Lilly USA, LLC | 5 | $95 |
| Viatris Specialty LLC | 4 | $84 |
| GlaxoSmithKline, LLC. | 4 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| PFIZER INC. | 2 | $36 |
| ABBVIE INC. | 2 | $35 |
| Corcept Therapeutics | 2 | $32 |
| Amgen Inc. | 2 | $31 |
Products named: Ozempic, BREZTRI, MOUNJARO, YUPELRI, TRINTELLIX, Wegovy, ELIQUIS, SHINGRIX.
Industry payments across IL — which companies pay providers there.
